Stardust Power Inc. SEC filings SDSTW
Stardust Power Inc. has 490 filings in SEC EDGAR's recent list, going back to Nov 20, 2020. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (listing notice, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Apr 21, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Apr 10, 2026 |
| DEF 14A | Proxy statement | Apr 28, 2025 | Apr 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2025 | Apr 17, 2025 |
| DEFA14A | Additional proxy material | Jun 21, 2024 | — |
| DEFM14A | Filing | May 23, 2024 | — |
| DEF 14A | Proxy statement | Dec 18, 2023 | Jan 9, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 8, 2023 | Dec 8, 2023 |
| DEFA14A | Additional proxy material | Jan 10, 2023 | — |
| DEF 14A | Proxy statement | Dec 23, 2022 | Jan 11, 2023 |
| PRE 14A | Preliminary proxy statement | Dec 13, 2022 | Dec 13, 2022 |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Primary Smelting & Refining of Nonferrous Metals (SIC 3330)
- Listed as
- SDST (Nasdaq), SDSTW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Oklahoma City, OK
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1831979
- Former names
- Stardust Power Inc. (until Oct 19, 2026); Global Partner Acquisition Corp II (until Jun 28, 2024)
Source: SEC EDGAR filings. This is company-reported data, not investment advice.